“…The trend towards outsourcing and in particular offshore manufacturing (Bhatnagar and Sohal, 2005;Peck, 2005;Zsidisin et al, 2005;Christopher and Holweg, 2011) has increased vulnerability to a range of disturbances such as hurricanes, earthquakes, political instability, etc. (Chopra andSodhi, 2004, 2014;Craighead et al, 2007;Ellis et al, 2011) and economic factors such as wage inflation in lower cost countries (Simchi-Levi, 2010;Wagner and Neshat, 2012). Pharmaceutical MNC supply chain vulnerability to disturbances was exposed by the 2011 Japanese earthquake and tsunami that led to (among many other serious problems) interruptions in the supply of glycine, an ingredient for solid-dosage products and the gelatine used in soft gel capsules (Miller, 2011).…”